Activity of the triazole antifungal R126638 as assessed by corneofungimetry

Skin Pharmacology and Physiology

Volumn 19, Issue 1, 2005, Pages 50-56

  Pierard Franchimont C ^a   Ausma, J ^b   Wouters, L ^b   Vroome, V ^b   Vandeplassche, L ^b   Borgers, M ^b,c   Cauwenbergh, G ^d   Pierard G E ^a,e  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b Barrier Therapeutics   (Belgium)

^c MAASTRICHT UNIVERSITY   (Netherlands)

^d Barrier Therapeutics   (United States)

^e CHU SART TILMAN   (Belgium)

Author keywords

Antifungal; Bioassay; Corneofungimetry; Dermatophyte; Skin; Yeast

Indexed keywords

ANTIFUNGAL AGENT; AZOLINE; TRIAZOLE DERIVATIVE; UNCLASSIFIED DRUG;

ADULT; ANTIFUNGAL ACTIVITY; ARTICLE; BIOASSAY; CANDIDA ALBICANS; COMPUTER ANALYSIS; CORNEOFUNGIMETRY; DIFFUSION; FOREARM; FUNGAL CELL; FUNGUS CULTURE; FUNGUS GROWTH; GROWTH INHIBITION; HUMAN; HUMAN CELL; IMAGE ANALYSIS; MALASSEZIA; MALASSEZIA GLOBOSA; MALE; MICROSPORUM CANIS; NORMAL HUMAN; PRIORITY JOURNAL; SKIN SURFACE; STATISTICAL SIGNIFICANCE; STRATUM CORNEUM; TRICHOPHYTON MENTAGROPHYTES; TRICHOPHYTON RUBRUM; VOLUNTEER;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; ANTIFUNGAL AGENTS; BIOLOGICAL ASSAY; DERMATOMYCOSES; EPIDERMIS; FUNGI; HUMANS; IMIDAZOLES; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; TISSUE ADHESIVES; TRIAZOLES;

EID: 28744445474     PISSN: 16605527     EISSN: None     Source Type: Journal    
DOI: 10.1159/000089143     Document Type: Article

References (29)

1. Odds F, Van Gerven F, Woestenborghs F, Meerpoel L, Heeres J, Vanden Bossche A, Borgers M: Activity in vitro and in vivo of a novel azole antifungal agent: R126638. Antimicrob Agents Chemother 2004;48:388-391.
2. Vanden Bossche H, Ausma J, Bohets H, Vermuyten K, Willemsens G, Marichal P, Meerpoel L, Odds F, Borgers M: The novel azole R126638 is a selective inhibitor of ergosterol synthesis in Candida albicans, Trichophyton spp. and Microsporum canis. Antimicrob Agents Chemother 2004;48:3272-3278.
3. Rurangirwa A, Piérard-Franchimont C, Piérard GE: Culture of fungi on cyanoacrylate skin surface strippings: a quantitative bioassay for evaluating antifungal drugs. Clin Exp Dermatol 1989;59:425-428.
4. Arrese JE, De Doncker P, Odds F, Piérard GE: Reduction in the growth of non-dermatophyte molds by itraconazole: evaluation by the corneofungimetry bioassay. Mycoses 1998;41:461-465.
5. Knight AG: Culture of dermatophytes upon stratum corneum. J Invest Dermatol 1973;59:427-432.
6. Faergemann J, Aly R, Maibach HI: Growth and filament production of Pityrosporum orbiculare and P. ovale on human stratum corneum in vitro. Acta Derm Venereol 1983;63:388-392.
7. Faergemann J: A new model for growth and filament production of Pityrosporum ovale (orbiculare) on human stratum corneum in vitro. J Invest Dermatol 1989;92:117-119.
8. Aljabre SHM, Richardson MD, Scott EM, Shakland GS: Germination of Trichophyton mentagrophytes on human stratum corneum in vitro. J Med Vet Mycol 1992;30:145-152.
9. Piérard GE, Rurangirwa A, Piérard-Franchimont C: Bioavailability of fluconazole and ketoconazole in human stratum corneum and oral mucosa. Clin Exp Dermatol 1991;16:167-171.
10. Piérard GE, Arrese JE, De Doncker P: Antifungal activity of itraconazole and terbinafine in human stratum corneum: a comparative study. J Am Acad Dermatol 1995;32:429-435.
11. Arrese JE, Fogouang L, Piérard-Franchimont C, Piérard GE: Euclidean and fractal computer-assisted corneofungimetry. A comparison of 2% ketoconazole and 1% terbinafine topical formulations. Dermatology 2002;204:222-227.
12. Piérard GE, Arrese JE, Piérard-Franchimont C: Itraconazole corneofungimetry bioassay on Malassezia species. Mycoses 2004;47:418-421.
13. Piérard-Franchimont C, Vroome V, Cauwenbergh G, Piérard GE: Corneofungimetry bioassay on Malassezia spp. under ketoconazole and desonide influences. Skin Pharmacol Physiol 2005;18:98-102.
14. Gallo RL, Murakami M, Ohtake T, Zaiou M: Biology and clinical relevance of naturally occurring antimicrobial peptides. J Allergy Clin Immunol 2002;110:823-831.
15. Janeway CA, Medzhitov R: Innate immune recognition. Annu Rev Immunol 2002;20:197-216.
16. Zasloff M: Antimicrobial peptides of multicellular organisms. Nature 2002;415:389-395.
17. Dorschner RA, Lopez-Garcia B, Massie J, Kim C, Gallo RL: Innate immune defense of the nail unit by antimicrobial peptides. J Am Acad Dermatol 2004;50:343-348.
18. Roeder A, Kirschning CJ, Rupee RA, Schaller M, Weindl G, Korting HC: Toll-like receptors as key mediators in innate antifungal immunity. Med Mycol 2004;42:485-498.
19. Naka W, Hanyaku H, Tajima S, Harada T, Nishikawa T: Application of neutral red staining for evaluation of the viability of dermatophytes and Candida in human skin scales. J Med Vet Mycol 1994;32:31-35.
20. SAS Procedures Guide, version 8, Cary, SAS Institute Inc., 1999.
21. Osborne CS, Leitner I, Favre B, Ryder NS: Antifungal drug response in an in vitro model of dermatophyte nail infection. Med Mycol 2004;42:159-163.
22. Arrese JE, Piérard GE: Treatment failures and relapses in onychomycosis: a stubborn clinical problem. Dermatology 2003;207:255-260.
23. Ausma J, Bruynseels J, Snoeck E, Blockhuys S, van Rossem K, Borgers M: Placebo-controlled randomized double-blind multiple dose dose-rising trial in healthy volunteers to assess tolerability, safety and pharmacokinetics of the novel antifungal R126638. J Eur Acad Dermatol Venereol 2004;18(suppl 2):392.
24. Piérard-Franchimont C, Piérard GE, Arrese JE, De Doncker P: Effect of ketoconazole 1% and 2% shampoos on severe dandruff and seborrhoeic dermatitis: clinical, squamometric and mycological assessments. Dermatology 2001;202:171-176.
25. Faergemann J, Bergbrant IM, Dohse M, Scott A, Westgate G: Seborrhoeic dermatitis and Pityrosporum (Malassezia) folliculitis: characterization of inflammatory cells and mediators in the skin by immunohistochemistry. Br J Dermatol 2001;144:549-556.
26. Faergemann J: Management of seborrheic dermatitis and pityriasis versicolor. Am J Clin Dermatol 2000;1:75-80.
27. Piérard GE, Piérard-Franchimont C, Van Cutsem J, Rurangirwa A, Hoppenbrouwers ML, Schrooten P: Ketoconazole 2% emulsion in the treatment of seborrheic dermatitis. Int J Dermatol 1991;30:806-809.
28. Piérard GE: Seborrheic dermatitis today, gone tomorrow? The link between the bioscene and treatment. Dermatology 2003;206:233-240.
29. Meerpoel L, Backx L, Van der Veken L, Heeres J, Corens D, De Groot A, Odds F, Van Gerven F, Woestenborghs F, Van Breda A, Oris M, Van Dorsselaer P, Willemsens G, Vermuyten K, Marichal P, Vanden Bossche H, Ausma J, Borgers M: Synthesis and in vitro and in vivo structure-activity relationships of novel antifungal triazoles for dermatology. J Med Chem 2005;48:2184-2193.